MISSISSAUGA, ON, Oct. 17, 2014 /CNW/ – Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that it has completed the sale of its PENNSAID 2% U.S. sales and marketing rights to Horizon Pharma plc (NASDAQ:HZNP) for a cash payment ofUS$45 million (CDN$50 million) which was payable on closing. Please click here to view the full press release.
Month: October 2014
SAN DIEGO, CA–(Marketwired – October 08, 2014) – iWallet Corporation (OTCQB: IWAL), the secure luxury techcessories company, announced it has appointed three new members to its board of directors including Carl Rosen, former COO of Bulova, then international consumer luxury goods company; Charles Ng, VP of sales at NEXT Biometrics and the former North American director of sales for Fingerprint Cards and sales director for Authentec, a biometric fingerprint technology; and Anthony Durkacz, EVP of the investment firm First Republic Capital Corporation. Click Here
Sherwood Park, Alberta / TNW-ACCESSWIRE / September 30, 2014 / Virtutone Networks Inc. (“Virtutone” or the “Company”) (TSX Venture: VFX.V) is pleased to announce its financial results for the three and six -month period ended July 31, 2014. Click Here